RGEN Q1 2017 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q1 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$31M+21.9% YoY

Gross Profit

$17M54.3% margin

Operating Income

$6M18.6% margin

Net Income

$3M10.0% margin

EPS (Diluted)

$0.09

QoQ Revenue Growth

+19.5%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

-$148,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$291M

Total Liabilities

$114M

Stockholders' Equity

$177M

Cash & Equivalents

$130M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$25M	+21.9%
Gross Profit	$17M	$14M	+18.4%
Operating Income	$6M	$3M	+63.9%
Net Income	$3M	$2M	+88.8%